Showing posts with label government. Show all posts
Showing posts with label government. Show all posts

Sunday, 22 March 2020

Vaccine Adjuvants Market : Future of biotechnology , it is Creating Real Change in the biotechnology Industry


The global vaccine adjuvants market is expected to reach USD 769.4 Million by 2021 from USD 467.0 Million in 2016, at a CAGR of 10.5%. The global market is broadly classified into product type, route of administration, disease type, applications, and application categories.

The global market is broadly classified into product type, route of administration, disease type, applications, and application categories.
On the basis of product type, the market is segmented into pathogen components, adjuvant emulsions, particulate adjuvants, combination adjuvants, and other adjuvants.

Access Free Sample Research Copy : 
https://www.marketsandmarkets.com/requestsampleNew.asp?id=152603894

                         
Global Vaccine Adjuvants Market Segmentation:

The global market is broadly classified into product type, route of administration, disease type, applications, and application categories.

+ On the basis of product type, the vaccine adjuvants market is segmented into pathogen components, adjuvant emulsions, particulate adjuvants, combination adjuvants, and others. The particulate adjuvants segment is expected to account for the largest share of the global market in 2016. The adjuvant emulsions segment, on the other hand, is projected to grow at the highest CAGR during the forecast period.

+ On the basis of route of administration, the market is segmented into oral, subcutaneous, intranasal, intramuscular, intradermal, and others. The intramuscular segment is expected to account for the largest share of the global vaccine adjuvants market in 2016.

+ On the basis of disease type, the vaccine adjuvants market is segmented into infectious diseases, cancer, and others. The infectious diseases segment is expected to account for the largest share of the global market in 2016. Factors such as high prevalence of infectious diseases, government & company initiatives, and high prevalence of cancer cases are expected to drive market growth in the coming years.

Download PDF Brochure : https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=152603894

What Drives the Market?

1. Increasing Use of Adjuvants in Vaccine
2. High Prevalence of Infectious and Zoonotic Diseases
3. Increase in Livestock and Instances of Diseases
4. Increasing Focus on Immunization Programs From Various Government Bodies
5. Technological Advancements in Aluminum Hydroxide-Based Adjuvants
6. Increasing Focus and Support on the Discovery and Development of Vaccine Adjuvants
7. Increasing Geriatric Population

Get Expert Analysis and Insights of Global Market | Request Sample Report: https://www.marketsandmarkets.com/requestsampleNew.asp?id=152603894

Geographical Growth Analysis:

Geographically, the vaccine adjuvants market is dominated by North America, followed by Europe, Asia, and the Rest of the World (RoW). However, Asia is projected to grow at the highest CAGR during the forecast period. Growth in the North American segment is primarily driven by the increasing geriatric population and rising incidences of diseases in the North American countries.

Wednesday, 18 March 2020

Cell Therapy Technologies Market by Product, Cell Type, Process Stages, End User, and Region - Global Forecast to 2023


Rising government investments for cell-based research, the increasing number of GMP-certified production facilities, and the large number of oncology-oriented cell-based therapy clinical trials are the key factors driving the growth of this market. China, India, Japan, Korea, and Brazil are emerging markets for cell therapy instruments.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=889




These markets boast comparatively lenient standards and government regulations as opposed to developed markets in North America and the EU, and thus offer significant growth potential for providers. However, the high cost of cell-based research and the low success rate is expected to restrain market growth to some extent during the forecast period.

Cell processing segment to witness the highest growth during the forecast period :

Based on process, the cell therapy technologies market is segmented into cell processing; cell preservation, distribution, and handling; and process monitoring and quality control. The cell processing segment is expected to account for the largest market share in 2018 and is projected to witness the highest CAGR during the forecasted period.

Browse and in-depth TOC on “Cell Therapy Technologies Market”
75 - Tables

30 - Figures

116 - Pages

To Get Sample Report @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=213334978

Key players in this market include Beckman Coulter (US), Becton, Dickinson and Company (US), GE Healthcare (US), Lonza (Switzerland), Merck KGaA (Germany), Miltenyi Biotec (Germany), STEMCELL Technologies, Inc. (Canada), Terumo BCT (US), and Thermo Fisher Scientific (US).

Thermo Fisher was the largest player in the Cell Therapy Technologies Market in 2017. In order to maintain its position in the market and further expand its product portfolio, the company focuses on the strategies of product launches, acquisitions, and expansions. Merck holds the second position in the cell therapy technologies market. The company focuses on collaborations, agreements, and acquisitions to enhance its market position.

North America to dominate the cell therapy technologies market during the forecast period :

The market is segmented into four major regions, namely, North America, Europe, Asia Pacific, and the Rest of the World (RoW). North America is expected to dominate the market in 2018 owing to the high burden of chronic diseases and increasing R&D activities in the pharmaceutical and biotechnology industries.

Speak to Analyst @ https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=213334978

Thursday, 20 February 2020

Vaccine Adjuvants Market | Analysis of Worldwide Industry Trends and Opportunities


The global vaccine adjuvants market is expected to reach USD 769.4 Million by 2021 from USD 467.0 Million in 2016, at a CAGR of 10.5%. The global market is broadly classified into product type, route of administration, disease type, applications, and application categories.

The global market is broadly classified into product type, route of administration, disease type, applications, and application categories.
On the basis of product type, the market is segmented into pathogen components, adjuvant emulsions, particulate adjuvants, combination adjuvants, and other adjuvants.

Download PDF Brochure : https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=152603894

                              

What Drives the Market?
1. Increasing Use of Adjuvants in Vaccine
2. High Prevalence of Infectious and Zoonotic Diseases
3. Increase in Livestock and Instances of Diseases
4. Increasing Focus on Immunization Programs From Various Government Bodies
5. Technological Advancements in Aluminum Hydroxide-Based Adjuvants
6. Increasing Focus and Support on the Discovery and Development of Vaccine Adjuvants
7. Increasing Geriatric Population

Global Vaccine Adjuvants Market Segmentation:

The global market is broadly classified into product type, route of administration, disease type, applications, and application categories.

+ On the basis of product type, the vaccine adjuvants market is segmented into pathogen components, adjuvant emulsions, particulate adjuvants, combination adjuvants, and others. The particulate adjuvants segment is expected to account for the largest share of the global market in 2016. The adjuvant emulsions segment, on the other hand, is projected to grow at the highest CAGR during the forecast period.

+ On the basis of route of administration, the market is segmented into oral, subcutaneous, intranasal, intramuscular, intradermal, and others. The intramuscular segment is expected to account for the largest share of the global vaccine adjuvants market in 2016.

+ On the basis of disease type, the vaccine adjuvants market is segmented into infectious diseases, cancer, and others. The infectious diseases segment is expected to account for the largest share of the global market in 2016. Factors such as high prevalence of infectious diseases, government & company initiatives, and high prevalence of cancer cases are expected to drive market growth in the coming years.

Get Expert Analysis and Insights of Global Market | Request Sample Report: https://www.marketsandmarkets.com/requestsampleNew.asp?id=152603894

Geographical Growth Analysis:

Geographically, the vaccine adjuvants market is dominated by North America, followed by Europe, Asia, and the Rest of the World (RoW). However, Asia is projected to grow at the highest CAGR during the forecast period. Growth in the North American segment is primarily driven by the increasing geriatric population and rising incidences of diseases in the North American countries.

Tuesday, 28 January 2020

Western Blotting Market : Worldwide Industry Analysis and New Opportunities Explored


According to the new market research report “Western Blotting Market by Product (Instruments, Consumables), Application (Biomedical & Biochemical Research, Disease Diagnostics), End User (Academic & Research Institutes, Pharmaceutical & Biotechnology Companies) - Global Forecasts to 2021", published by MarketsandMarkets™, This report studies the global western blotting market for the forecast period of 2016 to 2021.

In the coming years, the market is expected to witness the highest growth in the Asia-Pacific region. This can be attributed to increasing government interest in biomedical & biotechnology industry in China, government initiatives supported by funding in Japan, growing funding for agriculture research in India, increasing diagnosis and related funding in Australia, and growing prevalence of herpes simplex virus (HSV) in southeast Asia.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=235810711



The growth of the overall market can be attributed to the increasing number of research activities and R&D spending by pharmaceutical and biotechnology companies, rising prevalence of HIV/AIDS, and growing proteomics market are key factors driving the demand for western blotting instruments and consumables, increasing demand for personalized medicine, and new product launches are some of the other factors driving the growth of this market.

North America is expected to account for the largest share of the global market. This can be attributed to the increasing prevalence of HIV and Lyme disease in the U.S., rise in research funding and increasing production of genetically modified crops in the U.S., U.S.-China collaborative program for biomedical research, and HIV vaccine initiative in Canada.

Get Expert Analysis and Insights of Global Market | Request Sample Report: https://www.marketsandmarkets.com/requestsampleNew.asp?id=235810711

The report segments market based on product, application, end user, and region.

The western blotting market, by product is segmented into instruments and consumables. Consumables segment is expected to account for the largest share of the market, by product in 2016. This segment is also expected to grow at the highest CAGR during the forecast period. The western blotting instruments are further classified into gel electrophoresis instruments, blotting systems, and imagers.

The global market, based on the application is segmented into biomedical & biochemical research, disease diagnostics, agriculture, disease diagnostics, biologics, and quality control, among others.

Based on the end user, the western blotting market is segmented into academic & research institutes, diagnostic centers, pharmaceutical & research laboratories, diagnostic centers, forensic laboratories, and contract research organizations (CROs), among others. In 2016, the academic & research institutes segment is expected to command the largest share of the global market, by end user.

Bio-Rad Laboratories, Inc. (U.S.), Thermo Fisher Scientific, Inc. (U.S.), GE Healthcare (U.S.), Advansta, Inc. (U.S.), LI-COR Biosciences (U.S.), PerkinElmer, Inc. (U.S.), Bio-Techne Corporation (U.S.), Merck KGaA (Germany), F. Hoffmann-La Roche Ltd. (Switzerland), and Cell Signaling Technology, Inc. (U.S.) are some of the key players in the market worldwide.

Speak to Analyst: https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=235810711

Tuesday, 17 December 2019

What are the major applications of Bioinformatics market ?


 The growing demand for nucleic acid and protein sequencing due to a reduction in sequencing costs, increasing research initiatives from government and private organizations, and the growing applications of bioinformatics are the major factors driving the growth of the market.

Download PDF Brochure : https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=39

                
          
The global bioinformatics market is projected to reach USD 13.50 billion in 2023 from USD 6.17 billion in 2017, at CAGR of 14.5%. The base year considered for the study is 2017, and the forecast for the market size is provided for the period between 2018 and 2023.

* The global bioinformatics market is projected to reach USD 13.50 billion in 2023 from USD 7.73 billion in 2018, at CAGR of 14.5%.
* Growing demand for nucleic acid and Protein Sequencing and the rising applications of bioinformatics in drug discovery, clinical diagnostics, and personalized medicine are key factors supporting the growth of this market.
* On the other hand, a lack of well-defined standards and common formats for Data Integration may limit market growth to a certain extent.

Some of The Major Players In Synthetic Biology Market:
1. Thermo Fisher Scientific
2. Illumina Inc
3. Agilent Technologies
4. QIAGEN
5. BGI
6. Wuxi NextCODE
7. Eurofins Scientific

Get Sample Copy of This Report: https://www.marketsandmarkets.com/requestsampleNew.asp?id=39

In this report, the market has been classified based on product & service, applications, sectors, and region. Based on product and service, the market is segmented into knowledge management tools, bioinformatics platforms, and bioinformatics services. In 2018, the knowledge management tools segment is expected to account for the largest share of the market. The bioinformatics platforms segment is projected to grow at the highest rate during the forecast period. This high growth is attributed to an increase in the use of bioinformatics platforms in drug discovery and development.

Speak to Analyst: https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=39

On the basis of applications, the global market is divided into genomics, chemoinformatics and drug design, proteomics, transcriptomics, and metabolomics. In 2018, the genomics segment is expected to account for the largest share of the global market due to the increasing applications of genomics in personalized and preventive medicine.

North America is expected to account for the largest share of the bioinformatics market in 2018, followed by Europe. The APAC market, however, is projected to register the highest growth rate during the forecast period. Rising foreign investments and the growing penetration of cutting-edge research and clinical laboratory technologies are factors contributing to the growth of the APAC market. China is a major market in the Asia Pacific, whereas the markets in India and Japan are still in the growth phase.